Microbiological Features of Vancomycin in the 21st Century: Minimum Inhibitory Concentration Creep, Bactericidal/Static Activity, and Applied Breakpoints to Predict Clinical Outcomes or Detect Resistant Strains
Open Access
- 1 January 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (Supplement) , S13-S24
- https://doi.org/10.1086/491710
Abstract
The results of vancomycin susceptibility tests document that the drug continues to have activity against a wide variety of gram-positive pathogens. TKeywords
This publication has 78 references indexed in Scilit:
- Methicillin-ResistantStaphylococcus aureus1Emerging Infectious Diseases, 2004
- Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic MethodsAntimicrobial Agents and Chemotherapy, 2003
- Global Epidemiology of Antimicrobial Resistance among Community-Acquired and Nosocomial Pathogens: A Five-Year Summary from the SENTRY Antimicrobial Surveillance Program (1997-2001)Seminars in Respiratory and Critical Care Medicine, 2003
- The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus AureusAnnual Review of Microbiology, 2002
- Epidemiology of the Genetic Elements Responsible for Acquired Glycopeptide Resistance in EnterococciMicrobial Drug Resistance, 2001
- Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to GlycopeptidesJournal of Clinical Microbiology, 2001
- VANCOMYCIN-RESISTANT ENTEROCOCCIThe Lancet, 1988
- Problems in in vitro determination of antibiotic tolerance in clinical isolatesAntimicrobial Agents and Chemotherapy, 1986
- Antibiotic tolerance among clinical isolates of bacteriaAntimicrobial Agents and Chemotherapy, 1986
- Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981Antimicrobial Agents and Chemotherapy, 1983